Pfizer Pharmaceutical Titanium (FE) – Get the report He said there were no “data” to show that a single dose of his covid vaccine provided protection against the infection for more than 21 days, according to a press release.
Pfizer told Axios that some protection seems to start as early as 12 days after the first dose.
But the New York health care giant also said that two doses of vaccine, separated by three weeks, is the only treatment proven to be 95% effective in phase 3 studies, reports Axios.
He said it was important because the UK National Health Service had announced a change in its vaccination approach “to give as many people in at-risk groups as possible their first dose, rather than the two doses needed in the UK.” as short a time as possible ”.
The NHS said, “Everyone will still receive the second dose, and it will be within 12 weeks of their first.” The second dose completes the course and is important for longer term protection.
Pfizer shares were recently traded at $ 36.44, down 0.8%. They have fallen 1.8% this year because investors do not see that its finances benefit too much from the vaccine.
Morningstar analyst Damien Conover considers the shares to be slightly undervalued, putting the fair value at $ 40.
“We believe that the incredible speed of marketing the vaccine is consolidating [the] innovative power behind Pfizer’s wide ditch, ”he wrote this month.
But “we expect strong vaccine competition” from other companies, “which are likely to significantly stop the pandemic, but also reduce the profitability of the covid-19 vaccine market,” Conover said.
“We expect the price of vaccines to be reduced, with so many potential competitors.”